what is the difference between glp-1 and glp-2 receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal Glucagon-like peptide 1 (GLP-1) -

USPTO Patents Pending

Strive Hydrate+ is a pharmacist-formulated, electrolyte powder designed to support hydration, muscle function, and recovery

LipoCellTech technology involves the formation of microspheres from phospholipid bilayers that close back on themselves

It is not applicable in routine human clinical practice

The body naturally produces glucagon-like peptides, which are made up of 30 amino acids, to aid in the digestion and absorption of the foods we eat, regulate appetite, manage blood sugar levels, and contribute to overall metabolic homeostasis

Additionally, there are implications for patients with CKD and those undergoing hemodialysis